Vitalis Ortho raises £1.2m: Evertrace spotted Mac Tuncer 378 days earlier

Vitalis Ortho has raised £1.2m in pre-seed funding. The company is developing a joint-preserving approach for people with knee osteoarthritis.

Evertrace spotted Mac Tuncer, co-founder of Vitalis Ortho, 378 days before the funding announcement.

Before the round

On 11 June 2025, Evertrace spotted the first signal of company formation for co-founder Mac Tuncer. The signal showed the company taking shape 378 days before its funding announcement.

What they’re building

Vitalis Ortho is developing a medical device for patients whose symptoms are no longer controlled by conservative treatment but who are not yet suitable for knee replacement. Its work is focused on preserving the joint.

Co-founders Oliver Morgan and Mac Tuncer previously built Meshworks Implants. The new company is progressing through device testing and preclinical validation.

The round

Vitalis Ortho raised £1.2 million in an oversubscribed round co-led by Zinc and Aligned Syndicate. Orthopaedic Research UK, Innovate UK Growth Catalyst and angels participated. The funding supports testing as the company works toward first-in-human use.

Read the funding coverage →

Find your next investment before the round. Explore Evertrace →